Cover Image
市場調查報告書

人類微生物組的全球市場 2023年為止的預測:各適應症 (肥胖,癌症),各用途 (治療,診斷),各產品 (益生元,食品,藥物) 產品研究,技術研究 (高通量,體學技術)

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research, Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 312652
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
Back to Top
人類微生物組的全球市場 2023年為止的預測:各適應症 (肥胖,癌症),各用途 (治療,診斷),各產品 (益生元,食品,藥物) 產品研究,技術研究 (高通量,體學技術) Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research, Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023
出版日期: 2016年01月12日 內容資訊: 英文 147 Pages
簡介

本報告提供全球人類微生物組市場相關調查,提供您市場趨勢與發展趨勢,各適應症,各用途,各產品,各地區趨勢,並彙整主要參與企業的簡介等資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 威脅
    • 緊要問題

第6章 各產品市場

  • 簡介
  • 益生菌
  • 食品
  • 益生元
  • 醫療用食品
  • 診斷設備
  • 藥物
  • 其他益生菌補充品

第7章 各用途市場

  • 簡介
  • 治療
  • 診斷

第8章 不同疾病市場

  • 簡介
  • 急性的腹瀉
  • 肥胖
  • 糖尿病
  • 自體免疫疾病
  • 癌症
  • 精神疾病
  • 其他

第9章 各產品市場

  • 簡介
  • 設備
  • 消耗品

第10章 各技術市場

  • 簡介
  • 細胞培養技術
  • 高通量技術
  • 體學技術
  • 電腦工具

第11章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭環境

  • 概要
  • 競爭趨勢

第13章 企業簡介

第14章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2711

Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market

The product segment is expected to account for the largest share of the human microbiome market in the coming years. The high growth in this segment is attributed to the expectations to bring promising microbiome products to the market to help individual for the treatment of chronic diseases and various disorders at early stages and also due to increased curiosity among people to stay fit and have healthy lifestyle. The ability of these products to combat the fatal lifestyle diseases and maintain good health among the diseased population with the use of effective microbiome-based drugs and diagnostics devices will influence the market growth.

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The APAC region is expected to register the highest growth rate due to its immense growth opportunities and manufacturing cost benefits, while the U.S. is comparatively underdeveloped. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as "friendly" bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, rising incidences of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics. The evidence from intransigent research resulted the use of microbiomes as biomarkers and diagnosis of various diseases.

The disease segment, on the other hand, will be the fastest-growing segment in the coming years. With the growing incidences and increasing awareness of lifestyle diseases this market is set to grow at a fast pace.

The grey area while estimating the market size was the uncertainty factor that lies with the current regulatory scenario for various products. The insights were provided by the industry experts who later clarified as to which disease segment will witness product approvals by the regulatory authorities and will enter the market in the future.

From an insight perspective, this research report focuses on the qualitative data, future market size, share, and market potential of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It mainly focuses on the emerging and high-growth segments of the human microbiome market and the initiatives of their respective governments.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
    • 2.2.3. KEY INDUSTRY INSIGHTS
    • 2.2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HUMAN MICROBIOME MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: HUMAN MICROBIOME MARKET, BY PRODUCT
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE HUMAN MICROBIOME MARKET
  • 4.4. HUMAN MICROBIOME MARKET, BY PRODUCT, 2019 VS. 2023
  • 4.5. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2015 VS. 2020
  • 4.6. LIFE CYCLE ANALYSIS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Human microbiome therapy, an emerging market
      • 5.3.1.2. Human microbiome as a new validated target
      • 5.3.1.3. Need for early disease detection and diagnosis driving the use of microbiomes in molecular diagnostics
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Lack of expertise, proper detailed research
      • 5.3.2.2. Barriers to prove causal link between dysbiosis and disease
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Investigational New Drug (IND) requirements for fecal microbiota may boost market growth
      • 5.3.3.2. Joint ventures, collaborations, & partnerships
    • 5.3.4. THREATS
      • 5.3.4.1. Government regulations
    • 5.3.5. BURNING ISSUES
      • 5.3.5.1. Abundant opportunities in the microbiome field and tremendous research investments
      • 5.3.5.2. Development of microbiome therapeutic products

6. HUMAN MICROBIOME MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. PROBIOTICS
  • 6.3. FOODS
  • 6.4. PREBIOTICS
  • 6.5. MEDICAL FOODS
  • 6.6. DIAGNOSTIC DEVICES
  • 6.7. DRUGS
  • 6.8. OTHER PROBIOTIC SUPPLEMENTS

7. HUMAN MICROBIOME MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. THERAPEUTICS
  • 7.3. DIAGNOSTICS

8. HUMAN MICROBIOME MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. ACUTE DIARRHEA
  • 8.3. OBESITY
  • 8.4. DIABETES
  • 8.5. AUTOIMMUNE DISORDERS
  • 8.6. CANCER
  • 8.7. MENTAL DISORDERS
  • 8.8. OTHER DISEASES

9. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT

  • 9.1. INTRODUCTION
  • 9.2. INSTRUMENTS
    • 9.2.1. LABORATORY INSTRUMENTS
    • 9.2.2. ANALYZERS
  • 9.3. CONSUMABLES
    • 9.3.1. KITS
    • 9.3.2. REAGENTS

10. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY

  • 10.1. INTRODUCTION
  • 10.2. CELL CULTURE TECHNOLOGY
  • 10.3. HIGH-THROUGHPUT TECHNOLOGY
  • 10.4. OMICS TECHNOLOGY
  • 10.5. COMPUTATIONAL TOOLS

11. GEOGRAPHIC ANALYSIS

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
  • 11.4. ASIA-PACIFIC
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. COMPETITIVE SITUATION AND TRENDS
    • 12.2.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.2.2. ACQUISITIONS & EXPANSIONS
    • 12.2.3. NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS
    • 12.2.4. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 13.1. GEOGRAPHIC REVENUE MIX OF THE THREE MARKET PLAYERS
  • 13.2. ENTEROME BIOSCIENCE
  • 13.3. E.I. DU PONT DE NEMOURS AND COMPANY
  • 13.4. MERCK & CO., INC.
  • 13.5. METABIOMICS CORPORATION
  • 13.6. YAKULT HONSHA CO., LTD.
  • 13.7. MICROBIOME THERAPEUTICS, LLC
  • 13.8. OSEL, INC.
  • 13.9. SECOND GENOME, INC.
  • 13.10. VITHERA PHARMACEUTICALS
  • 13.11. VEDANTA BIOSCIENCES, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: USE OF MICROBIOME IN EARLY DISEASE DETECTION AND DIAGNOSIS, A KEY DRIVER TO THE GROWTH OF THE MARKET
  • TABLE 2: LACK OF PROPER DETAILED RESEARCH CURBS MARKET GROWTH
  • TABLE 3: SIGNIFICANT IMPACT OF REGULATORY AUTHORITIES MAY BOOST MARKET GROWTH
  • TABLE 4: MODIFICATION OF REGULATORY PATHWAYS BY THE FDA MAY HAMPER THE GROWTH OF THE MARKET
  • TABLE 5: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2023 (USD MILLION)
  • TABLE 6: HUMAN MICROBIOME MARKET SIZE FOR PROBIOTICS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 7: HUMAN MICROBIOME FOODS MARKET, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 8: HUMAN MICROBIOME MARKET SIZE FOR PREBIOTICS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 9: HUMAN MICROBIOME MARKET SIZE FOR MEDICAL FOODS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 10: HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC DEVICES, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 11: HUMAN MICROBIOME MARKET SIZE FOR DRUGS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 12: HUMAN MICROBIOME MARKET SIZE FOR OTHER PROBIOTIC SUPPLEMENTS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 13: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2023 (USD MILLION)
  • TABLE 14: HUMAN MICROBIOME MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 15: HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 16: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2023 (USD MILLION)
  • TABLE 17: HUMAN MICROBIOME MARKET SIZE FOR ACUTE DIARRHEA, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 18: HUMAN MICROBIOME MARKET SIZE FOR OBESITY, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 19: HUMAN MICROBIOME MARKET SIZE FOR DIABETES, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 20: HUMAN MICROBIOME MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 21: HUMAN MICROBIOME MARKET SIZE FOR CANCER, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 22: HUMAN MICROBIOME MARKET SIZE FOR MENTAL DISORDERS, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 23: HUMAN MICROBIOME MARKET SIZE FOR OTHER DISEASES, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 24: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 25: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 26: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 33: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 35: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 40: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 44: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: HUMAN MICROBIOME MARKET SIZE, BY REGION, 2019-2023 (USD MILLION)
  • TABLE 49: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 50: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2023 (USD MILLION)
  • TABLE 51: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 57: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 58: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 61: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 65: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2023 (USD MILLION)
  • TABLE 66: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2023 (USD MILLION)
  • TABLE 67: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2023 (USD MILLION)
  • TABLE 68: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 69: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 72: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2023 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2023 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2023 (USD MILLION)
  • TABLE 75: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 76: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 77: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 78: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 79: ROW: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2023 (USD MILLION)
  • TABLE 80: ROW: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2023 (USD MILLION)
  • TABLE 81: ROW: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2023 (USD MILLION)
  • TABLE 82: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 83: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 84: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 85: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 86: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS , 2012-2015
  • TABLE 87: ACQUISITIONS & EXPANSIONS, 2012-2015
  • TABLE 88: NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AND PATENTS, 2012-2015
  • TABLE 89: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION AND DATA TRIANGULATION BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: HUMAN MICROBIOME MARKET SNAPSHOT (2019 VS. 2023)
  • FIGURE 6: PROBIOTICS SEGMENT TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE MICROBIOME RESEARCH SPENDING MARKET FROM 2015 TO 2020
  • FIGURE 8: CELL CULTURE TECHNOLOGIES TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015
  • FIGURE 9: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL HUMAN MICROBIOME MARKET, 2019
  • FIGURE 10: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS - DOMINANT STRATEGY PURSUED BY MARKET PLAYERS
  • FIGURE 11: GROWING PREVALENCE OF LIFESTYLE DISEASES AND INCREASING ACCEPTANCE OF MICROBIOME-BASED PRODUCTS ARE MAJOR GROWTH DRIVERS
  • FIGURE 12: PR0BIOTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2019
  • FIGURE 13: NORTH AMERICA POISED TO BE THE FASTEST-GROWING MARKET FROM 2019 TO 2023
  • FIGURE 14: PREBIOTICS SEGMENT POISED TO GROW AT THE HIGHEST CAGR FROM 2019 TO 2023
  • FIGURE 15: CELL CULTURE TECHNOLOGIES SEGMENT TO DOMINATE THE MICROBIOME RESEARCH SPENDING TECHNOLOGY MARKET IN 2015
  • FIGURE 16: NORTH AMERICA TO ENTER EXPONENTIAL GROWTH PHASE
  • FIGURE 17: HUMAN MICROBIOME AS A NEW VALIDATED TARGET FOR DRUG DEVELOPMENT MAY SPUR THE MARKET
  • FIGURE 18: FUNDS PROVIDED FOR MICROBIOME RESEARCH BY VARIOUS MEDICAL RESEARCH AGENCIES
  • FIGURE 19: PROBIOTICS EXPECTED TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: EUROPE WILL ACCOUNT FOR THE LARGEST SHARE OF THE PROBIOTICS MARKET IN 2019
  • FIGURE 21: NORTH AMERICA EXPECTED TO DOMINATE THE HUMAN MICROBIOME FOODS MARKET FROM 2019 TO 2023
  • FIGURE 22: INORGANIC GROWTH STRATEGIES BETWEEN COMPANIES WILL INCREASE THE DEMAND FOR MICROBIOME-BASED DRUGS IN EUROPE
  • FIGURE 23: THE THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME APPLICATIONS MARKET BY 2023
  • FIGURE 24: EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE THERAPEUTICS APPLICATION SEGMENT IN 2019
  • FIGURE 25: ACUTE DIARRHEA EXPECTED TO BE THE LARGEST DISEASE SEGMENT OF THE HUMAN MICROBIOME MARKET IN 2019
  • FIGURE 26: EUROPE IS ESTIMATED TO BE THE LARGEST HUMAN MICROBIOME MARKET FOR ACUTE DIARRHEA IN 2019
  • FIGURE 27: HUMAN MICROBIOME MARKET FOR OBESITY IS EXPECTED TO WITNESS HIGHEST GROWTH RATE IN NORTH AMERICA DURING THE FORECAST PERIOD
  • FIGURE 28: INSTRUMENTS SEGMENT TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT
  • FIGURE 29: EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE INSTRUMENTS SEGMENT IN 2015
  • FIGURE 30: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE CONSUMABLES MARKET FROM 2015 TO 2020
  • FIGURE 31: CELL CULTURE TECHNOLOGY SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020
  • FIGURE 32: EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL CULTURE TECHNOLOGY SEGMENT IN 2015
  • FIGURE 33: U.S. TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN HIGH-THROUGHPUT TECHNOLOGY MARKET BY 2020
  • FIGURE 34: CANADA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 35: NORTH AMERICA WILL BE THE FASTED-GROWING REGION IN THE COMPUTATIONAL TOOLS MARKET FROM 2015 TO 2020
  • FIGURE 36: GEOGRAPHIC SNAPSHOT (2019): NORTH AMERICA WILL BE THE FASTEST-GROWING REGION BY 2019
  • FIGURE 37: NORTH AMERICA SHOWS HIGH GROWTH POTENTIAL FOR THE HUMAN MICROBIOME RESEARCH SPENDING MARKET
  • FIGURE 38: DEMAND FOR HUMAN MICROBIOME WILL BE FUELED BY GROWING R&D AND RISING INCIDENCES OF LIFESTYLE DISEASES AND CHRONIC DISORDERS
  • FIGURE 39: EUROPE: MARKET SNAPSHOT
  • FIGURE 40: PREBIOTICS SEGMENT TO GROW AT THE FASTEST RATE IN THE APAC HUMAN MICROBIOME PRODUCT MARKET FROM 2019 TO 2023
  • FIGURE 41: CELL CULTURE TECHNOLOGY IS THE MOST COMMONLY USED TECHNOLOGY FOR HUMAN MICROBIOME RESEARCH IN 2015
  • FIGURE 42: COMPANIES ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
  • FIGURE 43: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS - KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE HUMAN MICROBIOME MARKET
  • FIGURE 44: E.I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 45: MERCK & CO., INC.: COMPANY SNAPSHOT
  • FIGURE 46: YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
Back to Top